MedPath

Effectiveness of Metformin and Lifestyle Interventions as Initial Treatment in Japanese Patients with Type 2 Diabetes (EMINENT Study)

Not Applicable
Conditions
Type 2 Diabetes
Registration Number
JPRN-UMIN000004193
Lead Sponsor
issay Hospital
Brief Summary

Satoru Sumitani, Shinya Morita, Yoshihiko Utsu, Kosuke Mukai, Shunji Miki, Bunzo Sato, Hideji Nakamura, Soji Kasayama. Effectiveness of metformin and lifestyle interventions asan initial treatment in Japanese patients with newly diagnosed type 2 diabetes : a prospective observational study. J. Med. Invest. 59 : 166-173, February, 2012

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

Type 1 diabetes. Patients contraindicated to metformin. Patients judged not to be eligible by the principal investigator.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in glycated hemoglobin (HbA1c) at 16 weeks after the initiation of the treatment
Secondary Outcome Measures
NameTimeMethod
Change in body weight, fasting plasma glucose, glycated albumin, total cholesterol, triglyceride, HDL-cholesterol, liver enzymes, and an incidence of adverse effects during treatment.
© Copyright 2025. All Rights Reserved by MedPath